Stocks
Moderna, Inc.MRNA
NASDAQHealthcareBiotechnology$52.56-1.55%
A biotechnology firm specializing in mRNA-based vaccines and therapeutics, Moderna gained prominence for its COVID-19 vaccine. Investors monitor its pipeline of mRNA treatments for infectious diseases, oncology, and rare diseases as a bellwether for the broader mRNA sector.
Market Cap: $20.8B52W Range: $22.28 – $59.55
Congressional Interest in Moderna, Inc. (MRNA)
6 members of Congress have disclosed 17 trades in Moderna, Inc. (MRNA), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 12 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
17
Unique Politicians
6
Buys
5
Sells
12
Who in Congress Is Trading MRNA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-03-15 | Josh Gottheimer | sell | $1K – $15K |
| 2021-01-29 | Marie Newman | sell | $15K – $50K |